article thumbnail

Technology Convergence Driving the Development of Sustainable Crop Protection Solutions

Frost & Sullivan

Furthermore, government strategies, such as proposing a 50% reduction in fertilizer losses and a 20% reduction in fertilizer consumption by 2030, are expected to drive innovation in the sustainable agrochemicals market. For further information on this analysis, please click here.

article thumbnail

Perspectives from Higher Education: Applied Sciences University Teachers on the Digitalization of the Bioeconomy

TIM Review

The term “bioeconomy” covers multiple scientific fields and interrelated perspectives highlighting biotechnology, bio-resources, and bio-ecology (Bugge et al., Higher Education Institutes Digivision 2030. If we don't change, we don't grow. . Gail Sheehy. Introduction . The macro level context also has an impact. Digital disruption.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

10 Game-Changing Transformations Reshaping the Global Molecular Biomarkers Industry by 2030

Frost & Sullivan

The landscape of global molecular biomarkers is rapidly evolving, driven by advancements in biotechnology and the increasing demand for personalized medicine. Organizations integrating digital health solutions, AI analytics, and direct-to-patient diagnostics will be best positioned for success by 2030 and beyond. Want deeper insights?

article thumbnail

Pharma & Biotech in 2025: The Top 6 Growth Opportunities Shaping the Future

Frost & Sullivan

The pharmaceutical and biotechnology industries are at the cusp of a transformative era in 2025, driven by cutting-edge innovation, evolving regulations, and increasing market pressures. By 2030, the RLT market is projected to reach $13.07 billion by 2030. The market for RLT is set for exponential growth. billion in sales.

Biotech 52
article thumbnail

The Global Growth of Cardiac Biomarkers Diagnostics: Innovations, Growth Drivers, and Opportunities (2024-2029)

Frost & Sullivan

million by 2030, emphasizing the need for early and accurate diagnostics. Elabscience Biotechnology, Inc., Download our full analysis on Cardiac Biomarkers Diagnostics. Click here to download According to the World Health Organization (WHO), CVD-related deaths are projected to reach 23.3 Quanterix, Response Biomedical Corp.,